BRVE Financials

Income Statement
MetricQ3 2026
Revenue
0
Cost of Revenue
0
Gross Profit
0
Operating Expenses
30.1M
R&D
17.5M
SG&A
12.6M
Operating Income
-30149000
EBITDA
-30146000
Net Income
-26495000
EPS (Basic)
$-0.51
EPS (Diluted)
$-0.51
Shares (Diluted)
52.1M
Braveheart Bio (BRVE) — Financials